These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38110594)

  • 1. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
    Whitehurst DA; Friedman DL; Zhao Z; Sarma A; Snyder E; Dulek DE; Banerjee R; Kitko CL; Esbenshade AJ
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30818. PubMed ID: 38110594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
    Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
    Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
    Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
    J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
    Otto WR; Dvorak CC; Boge CLK; Ostrosky-Zeichner L; Esbenshade AJ; Nieder ML; Alexander S; Steinbach WJ; Dang H; Villaluna D; Chen L; Skeens M; Zaoutis TE; Sung L; Fisher BT
    Pediatr Transplant; 2023 Feb; 27(1):e14399. PubMed ID: 36299233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of cell-free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients.
    Kushner LE; Schwenk HT; Qin F; Boothroyd D; Aftandilian C
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31133. PubMed ID: 38943234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
    Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
    Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
    Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
    Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia.
    Alali M; Giurcanu M; Elmuti L; Kumar M
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e334-e342. PubMed ID: 34224520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Predictive Factors of Invasive Fungal Disease in Pediatric Oncology Patients with Febrile Neutropenia in a Country with Limited Resources.
    Monsereenusorn C; Sricharoen T; Rujkijyanont P; Suwanpakdee D; Photia A; Lertvivatpong N; Traivaree C
    Pediatric Health Med Ther; 2021; 12():335-345. PubMed ID: 34285630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
    Giacobbe DR; Del Bono V; Viscoli C; Mikulska M
    Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1101-1112. PubMed ID: 29125373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit.
    Talento AF; Dunne K; Joyce EA; Palmer M; Johnson E; White PL; Springer J; Loeffler J; Ryan T; Collins D; Rogers TR
    J Crit Care; 2017 Aug; 40():119-127. PubMed ID: 28384600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic Value of G and GM Tests in Acute Leukemia Patients with Invasive Fungal Disease].
    Qian KY; Lyu QX; Dai LJ; Chang HR; Wu DP; Sun AN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1678-1681. PubMed ID: 31607331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies?
    Agrawal AK; Saini N; Gildengorin G; Feusner JH
    Pediatr Blood Cancer; 2011 Oct; 57(4):620-4. PubMed ID: 21265012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
    Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
    Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
    Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
    Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.